Not applicableStudy completedNCT05783336What this trial is testingStepping Stones and Creating Futures Plus PilotWho this might be right forIntimate Partner ViolencePoverty University of Exeter 325
Early research (Phase 1)Looking for participantsNCT05334004What this trial is testingLopinavir/Ritonavir in PLWH With High-Grade AINWho this might be right forHigh-Grade Anal Intraepithelial Neoplasia University of Wisconsin, Madison 21
Large-scale testing (Phase 3)Study completedNCT04542070What this trial is testingEvaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically SuppressedWho this might be right forHIV Infections ViiV Healthcare 687
Testing effectiveness (Phase 2)Study completedNCT01962961What this trial is testingN-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older AdultsWho this might be right forHIVEndothelial DysfunctionOxidative Stress Indiana University 24
Testing effectiveness (Phase 2)Study completedNCT06144086What this trial is testingTrial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)Who this might be right forLiver Cirrhosis Kiminori Kimura, MD 5
Not applicableEnded earlyNCT00001069What this trial is testingTwo Methods of Determining When to Begin or Change Anti-HIV TreatmentWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 1,100
Post-approval studies (Phase 4)Study completedNCT01332227What this trial is testingAtazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected PatientsWho this might be right forHIV, Combination Therapy Bristol-Myers Squibb 132
Early research (Phase 1)Study completedNCT00481182What this trial is testingCo-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.Who this might be right forHealthy Subjects GlaxoSmithKline 20
Not applicableUnknownNCT06062979What this trial is testingClinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in CareWho this might be right forHIV Whitman-Walker Institute 180
Early research (Phase 1)Study completedNCT00000656What this trial is testingA Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV DiseaseWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 116
Testing effectiveness (Phase 2)Study completedNCT04563377What this trial is testingSafety and Immunogenicity of Candidate HIV Vaccines Given SequentiallyWho this might be right forHealthy University of Oxford 10
Early research (Phase 1)Study completedNCT00000988What this trial is testingBMY-27857 in Patients With AIDS or AIDS Related ComplexWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00896051What this trial is testingTMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV PatientsWho this might be right forHIV InfectionsAcquired Immunodeficiency Syndrome Janssen R&D Ireland 50
Large-scale testing (Phase 3)Study completedNCT01516060What this trial is testingThe Neurocognitive Sub-study of Encore1Who this might be right forHIV Kirby Institute 71
Testing effectiveness (Phase 2)Study completedNCT00251537What this trial is testingA Pilot Study of LTB4 in HIV-1 Infected AdultsWho this might be right forHIV Infections LTB4 Sweden AB 40
Not applicableStudy completedNCT00993694What this trial is testingMethemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more Vanderbilt University 41
Large-scale testing (Phase 3)Study completedNCT01271894What this trial is testingThe Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)Who this might be right forHIV Infection Kirby Institute 40
Testing effectiveness (Phase 2)Study completedNCT03499795What this trial is testingVGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2Who this might be right forAnal Neoplasm Inovio Pharmaceuticals 23
Large-scale testing (Phase 3)Study completedNCT02429791What this trial is testingRegimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)Who this might be right forHIV Infections ViiV Healthcare 510
Testing effectiveness (Phase 2)Active Not RecruitingNCT06812494What this trial is testingVRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIVWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 200